NanoVy™ HA

NanoVy™ HA is a 20 nanometer thin implant surface modification composed of crystalline hydroxyapatite (HA) particles that through shape, composition, and structure mimic human bone tissue. NanoVy™ HA  has proven to significantly accelerate and enhance osseointegration of implants. The surface can be used on all implants regardless of material and geometry, making it ideal for lattice structures such as OsteoVy™ Ti. 

Jimbo R (2011), ‘Histological and three-dimensional evaluation of osseointegration’(data is derived from in vivo rabbit studies, these in vivo studies may not be representative of clinical experience )

 Titanium implants coated with NanoVy™ HA have been shown to have +67% Bone-to-Implant Contact when compared to uncoated titanium implants with the same base surface finish.

Meirelles L (2008), ‘The effect of Chemical and Nanotopographical Modification on the early stages of osseointegration’ (data is derived from in vivo rabbit studies, these in vivo studies may not be representative of clinical experience)

NanoVy™ HA coated titanium implants  demonstrate enhanced early bone integration by nearly 37% compared to uncoated titanium implants with the same base surface finish.

Jimbo R (2011), ‘Histological and three-dimensional evaluation of osseointegration’ (data is derived from in vivo rabbit studies, these in vivo studies may not be representative of clinical experience)

 The new bone tissue quality was significantly enhanced around the titanium implants with  NanoVy™ HA by over 120% in comparison to titanium implants without coating.

 Jimbo R (2012), ‘Nano hydroxyapatite-coated implants improve bone nanomechanical properties’.   (data is derived from in vivo rabbit studies, these in vivo studies may not be representative of clinical experience)

 NanoVy™ HA coatings enhance the hydrophilicity of titanium implants.  This may help the osseointegration of the implant and the surrounding bone.

Jimbo R (2011), ‘Histological and three-dimensional evaluation of osseointegration’ (data is derived from in vivo rabbit studies, these in vivo studies may not be representative of clinical experience)